tm logo

Monitor this mark

View On USPTO

SOOLANTRA
Live/Registered
REGISTERED AND RENEWED

on 29 Apr 2024

Last Applicant/ Owned by

GALDERMA HOLDING S.A.

Zahlerweg 10

Zug

CH

6300

Serial Number

85836047 filed on 30th Jan 2013

Registration Number

4490439 registered on 04th Mar 2014

in the Principal Register

Correspondent Address

Katherine P. Califa

Katherine P. Califa Foley & Lardner LLP

Washington, DC 20007-5109

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

SOOLANTRA

Pharmaceutical preparations for use in dermatology, namely, oral and topical drugs for the treatment of inflammatory disorders of the skin, namely, rosacea, dermatitis, psoriasis, acne, and eczema

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in dermatology, namely, oral and topical drugs for the treatment of inflammatory disorders of the skin, namely, rosacea, dermatitis, psoriasis, acne, and eczema

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 85836047

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 142225-8927

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
15th Nov 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15th Nov 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
15th Nov 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
15th Nov 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15th Nov 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15th Nov 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
15th Nov 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29th Apr 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
29th Apr 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
29th Apr 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)